{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:05:06Z","timestamp":1783008306382,"version":"3.54.5"},"reference-count":51,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,24]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Mycosis fungoides (MF) is characterized by stepwise evolution from patch to plaque and sometimes to tumor. Identifying patients with early-stage MF who could progress to an advanced stage is challenging. This study investigated changes in transcriptomic expression and the tumor microenvironment associated with MF progression. Spatially resolved transcriptomic profiling was conducted using CD3, CD4, and CD30 morphology markers. In the lymphoma cell area, genes linked to collagen fibril assembly and regulation of interleukin-4 were upregulated as the disease progressed from patch- to plaque-stage MF. Genes involved in the cell cycle and glutamate catabolism were upregulated during the transition from plaque- to tumor-stage MF. Forty-six significant genes that consistently increased in expression during progression were identified. Patients with stage I MF with high-progression signatures showed significantly increased cancer-associated fibroblast (CAF; P = .008) and were more likely to progress (P &amp;lt; .001) and receive radiation (P = .023) during follow-up. Furthermore, M2 macrophages significantly increased in lymphoma cell areas (P &amp;lt; .001) and immune cell areas (P = .031) in plaque-stage MF compared with patch-stage MF. CD163 expression was significantly correlated with most of the progression signatures and T-cell exhaustion markers (lymphocyte activation gene-3, T cell immunoglobulin and mucin-domain containing-3). Immunohistochemical staining revealed that several CAF markers and CD163 significantly increased during progression, and these markers were more frequently observed in progressive stage I MF compared with indolent stage I MF. In conclusion, this study identified significant transcriptomic changes during MF progression and found that tumor microenvironment, particularly M2 macrophages and CAFs, could contribute to progression in early-stage MF.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024014495","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T19:09:35Z","timestamp":1743448175000},"page":"2871-2885","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["Spatial transcriptomics of progression gene signature and tumor microenvironment leading to progression in mycosis fungoides"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7514-7873","authenticated-orcid":false,"given":"Myoung Eun","family":"Choi","sequence":"first","affiliation":[{"name":"1Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5350-2309","authenticated-orcid":false,"given":"Gyeonghoon","family":"Kim","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"},{"name":"2Department of Biomedical Engineering, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2873-3850","authenticated-orcid":false,"given":"Hwa-Jeong","family":"Shin","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1997-2240","authenticated-orcid":false,"given":"Chong Hyun","family":"Won","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4225-0414","authenticated-orcid":false,"given":"Sung Eun","family":"Chang","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4669-9454","authenticated-orcid":false,"given":"Mi Woo","family":"Lee","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0549-464X","authenticated-orcid":false,"given":"Woo Jin","family":"Lee","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"issue":"2","key":"2025062410265267900_bib1","doi-asserted-by":"crossref","first-page":"205.e1","DOI":"10.1016\/j.jaad.2013.07.049","article-title":"Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers","volume":"70","author":"Jawed","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"31","key":"2025062410265267900_bib2","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"2025062410265267900_bib3","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1182\/blood-2021-146590","article-title":"Risk factors for progression from early to advanced stage mycosis fungoides: a single center retrospective analysis at the Winship Cancer Institute of Emory University","volume":"138","author":"Allen","year":"2021","journal-title":"Blood"},{"issue":"6","key":"2025062410265267900_bib4","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/bjd.12909","article-title":"Prognostic factors, prognostic indices and staging in mycosis fungoides and S\u00e9zary syndrome: where are we now?","volume":"170","author":"Scarisbrick","year":"2014","journal-title":"Br J Dermatol"},{"issue":"4","key":"2025062410265267900_bib5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archderm.136.4.504","article-title":"Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients","volume":"136","author":"van Doorn","year":"2000","journal-title":"Arch Dermatol"},{"issue":"11","key":"2025062410265267900_bib6","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/jdv.12299","article-title":"Genetic markers associated with progression in early mycosis fungoides","volume":"28","author":"Johnson","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"2025062410265267900_bib7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archderm.139.7.857","article-title":"Long-term outcome of 525 patients with mycosis fungoides and S\u00e9zary syndrome: clinical prognostic factors and risk for disease progression","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"issue":"6","key":"2025062410265267900_bib8","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/bjd.12717","article-title":"A specific DNA methylation profile correlates with a high risk of disease progression in stage I classical (Alibert\u2013Bazin type) mycosis fungoides","volume":"170","author":"Ferrara","year":"2014","journal-title":"Br J Dermatol"},{"issue":"4","key":"2025062410265267900_bib9","first-page":"765","article-title":"Increased serum level of stem cell factor in association with disease progression of hyperpigmented mycosis fungoides [published correction appears in Br J Dermatol. 1999;141(5):100]","volume":"140","author":"Yamamoto","year":"1999","journal-title":"Br J Dermatol"},{"issue":"13","key":"2025062410265267900_bib10","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.ejca.2013.04.018","article-title":"A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and S\u00e9zary syndrome","volume":"49","author":"Benton","year":"2013","journal-title":"Eur J Cancer"},{"issue":"8","key":"2025062410265267900_bib11","doi-asserted-by":"crossref","first-page":"e1467856","DOI":"10.1080\/2162402X.2018.1467856","article-title":"Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients","volume":"7","author":"Lefran\u00e7ois","year":"2018","journal-title":"Oncoimmunology"},{"issue":"3","key":"2025062410265267900_bib12","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3390\/cancers15030746","article-title":"Mycosis fungoides and S\u00e9zary syndrome: microenvironment and cancer progression","volume":"15","author":"Dobos","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"10","key":"2025062410265267900_bib13","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.3390\/cells10102780","article-title":"The microenvironment's role in mycosis fungoides and S\u00e9zary syndrome: from progression to therapeutic implications","volume":"10","author":"Pileri","year":"2021","journal-title":"Cells"},{"issue":"2","key":"2025062410265267900_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jid.2023.05.030","article-title":"Spatially resolved transcriptomes of CD30+-transformed mycosis fungoides and cutaneous anaplastic large-cell lymphoma","volume":"144","author":"Choi","year":"2024","journal-title":"J Invest Dermatol"},{"issue":"21","key":"2025062410265267900_bib15","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1158\/0008-5472.CAN-16-0992","article-title":"Thymic stromal chemokine TSLP acts through Th2 cytokine production to induce cutaneous T-cell lymphoma","volume":"76","author":"Takahashi","year":"2016","journal-title":"Cancer Res"},{"issue":"1","key":"2025062410265267900_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jdermsci.2022.03.005","article-title":"Dermal fibroblasts promote cancer cell proliferation and exhibit fibronectin overexpression in early mycosis fungoides","volume":"106","author":"Beksa\u00e7","year":"2022","journal-title":"J Dermatol Sci"},{"issue":"3","key":"2025062410265267900_bib17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jid.2020.06.034","article-title":"Cancer-associated fibroblasts in mycosis fungoides promote tumor cell migration and drug resistance through CXCL12\/CXCR4","volume":"141","author":"Aronovich","year":"2021","journal-title":"J Invest Dermatol"},{"issue":"1","key":"2025062410265267900_bib18","doi-asserted-by":"crossref","first-page":"1.30.1","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr Protoc Bioinformatics"},{"issue":"1","key":"2025062410265267900_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13045-020-01005-x","article-title":"RNA sequencing: new technologies and applications in cancer research","volume":"13","author":"Hong","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"8","key":"2025062410265267900_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0071-8","article-title":"Single-cell RNA sequencing technologies and bioinformatics pipelines [published correction appears in Exp Mol Med. 2021;53(5):1005]","volume":"50","author":"Hwang","year":"2018","journal-title":"Exp Mol Med"},{"issue":"1","key":"2025062410265267900_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41368-021-00146-0","article-title":"From bulk, single-cell to spatial RNA sequencing","volume":"13","author":"Li","year":"2021","journal-title":"Int J Oral Sci"},{"issue":"18","key":"2025062410265267900_bib22","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-12-0604","article-title":"Long-term outcomes of 1,263 patients with mycosis fungoides and S\u00e9zary syndrome from 1982 to 2009","volume":"18","author":"Talpur","year":"2012","journal-title":"Clin Cancer Res"},{"key":"2025062410265267900_bib23","doi-asserted-by":"crossref","first-page":"1026954","DOI":"10.3389\/fimmu.2022.1026954","article-title":"Major pathways involved in macrophage polarization in cancer","volume":"13","author":"Kerneur","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"2025062410265267900_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jdermsci.2012.07.007","article-title":"Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma","volume":"68","author":"Sugaya","year":"2012","journal-title":"J Dermatol Sci"},{"issue":"2","key":"2025062410265267900_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/exd.12873","article-title":"The possible interaction between periostin expressed by cancer stroma and tumor-associated macrophages in developing mycosis fungoides","volume":"25","author":"Furudate","year":"2016","journal-title":"Exp Dermatol"},{"issue":"12","key":"2025062410265267900_bib26","doi-asserted-by":"crossref","first-page":"e004794","DOI":"10.1136\/jitc-2022-004794","article-title":"TIGIT blockade repolarizes AML-associated TIGIT(+) M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis","volume":"10","author":"Brauneck","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"1","key":"2025062410265267900_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/ijms22010075","article-title":"The next-generation immune checkpoint LAG-3 and its therapeutic potential in oncology: third time's a charm","volume":"22","author":"Lecocq","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2025062410265267900_bib28","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.3390\/jcm9082500","article-title":"Correlation between tumor-associated macrophage and immune checkpoint molecule expression and its prognostic significance in cutaneous melanoma","volume":"9","author":"Kim","year":"2020","journal-title":"J Clin Med"},{"issue":"9","key":"2025062410265267900_bib29","doi-asserted-by":"crossref","first-page":"e1211219","DOI":"10.1080\/2162402X.2016.1211219","article-title":"Tim-3 promotes tumor-promoting M2 macrophage polarization by binding to STAT1 and suppressing the STAT1-miR-155 signaling axis","volume":"5","author":"Jiang","year":"2016","journal-title":"Oncoimmunology"},{"issue":"12","key":"2025062410265267900_bib30","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/00000478-199512000-00009","article-title":"Reassessment of histologic parameters in the diagnosis of mycosis fungoides","volume":"19","author":"Smoller","year":"1995","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2025062410265267900_bib31","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/jid.2011.470","article-title":"Low herpesvirus entry mediator (HVEM) expression on dermal fibroblasts contributes to a Th2-dominant microenvironment in advanced cutaneous T-cell lymphoma","volume":"132","author":"Miyagaki","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"19","key":"2025062410265267900_bib32","doi-asserted-by":"crossref","first-page":"e170015","DOI":"10.1172\/jci.insight.170015","article-title":"The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis","volume":"8","author":"Gaydosik","year":"2023","journal-title":"JCI Insight"},{"issue":"10","key":"2025062410265267900_bib33","doi-asserted-by":"crossref","first-page":"e77366","DOI":"10.1371\/journal.pone.0077366","article-title":"TIMP-1 promotes accumulation of cancer associated fibroblasts and cancer progression","volume":"8","author":"Gong","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"2025062410265267900_bib34","doi-asserted-by":"crossref","first-page":"e1391","DOI":"10.1002\/ctm2.1391","article-title":"TIMP1 is an early biomarker for detection and prognosis of lung cancer","volume":"13","author":"Dantas","year":"2023","journal-title":"Clin Transl Med"},{"issue":"12","key":"2025062410265267900_bib35","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1111\/cas.15567","article-title":"TIMP1 promotes cell proliferation and invasion capability of right-sided colon cancers via the FAK\/Akt signaling pathway","volume":"113","author":"Ma","year":"2022","journal-title":"Cancer Sci"},{"key":"2025062410265267900_bib36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.matbio.2022.06.009","article-title":"Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma","volume":"111","author":"Duch","year":"2022","journal-title":"Matrix Biol"},{"issue":"1","key":"2025062410265267900_bib37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12943-016-0515-5","article-title":"Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer","volume":"15","author":"Cheng","year":"2016","journal-title":"Mol Cancer"},{"issue":"4","key":"2025062410265267900_bib38","doi-asserted-by":"crossref","first-page":"e95893","DOI":"10.1371\/journal.pone.0095893","article-title":"Rac2 controls tumor growth, metastasis and M1-M2 macrophage differentiation in vivo","volume":"9","author":"Joshi","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"2025062410265267900_bib39","first-page":"645","article-title":"RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma","volume":"55","author":"Liu","year":"2019","journal-title":"Int J Oncol"},{"issue":"1","key":"2025062410265267900_bib40","first-page":"8485726","article-title":"Pancancer analysis revealed the value of RAC2 in immunotherapy and cancer stem cell","volume":"2023","author":"Liu","year":"2023","journal-title":"Stem Cells Int"},{"issue":"6","key":"2025062410265267900_bib41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5021\/ad.2021.33.6.487","article-title":"The role of tumor microenvironment in mycosis fungoides and S\u00e9zary syndrome","volume":"33","author":"Liu","year":"2021","journal-title":"Ann Dermatol"},{"issue":"1","key":"2025062410265267900_bib42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12943-021-01419-2","article-title":"Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma","volume":"20","author":"Rindler","year":"2021","journal-title":"Mol Cancer"},{"issue":"1","key":"2025062410265267900_bib43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5021\/ad.2016.28.1.115","article-title":"Increasing numbers of mast cells in skin lesions of hyperpigmented mycosis fungoides with large-cell transformation","volume":"28","author":"Kondo","year":"2016","journal-title":"Ann Dermatol"},{"key":"2025062410265267900_bib44","doi-asserted-by":"crossref","first-page":"1197821","DOI":"10.3389\/fimmu.2023.1197821","article-title":"In the skin lesions of patients with mycosis fungoides, the number of MRGPRX2-expressing cells is increased and correlates with mast cell numbers","volume":"14","author":"Hu","year":"2023","journal-title":"Front Immunol"},{"key":"2025062410265267900_bib45","doi-asserted-by":"crossref","first-page":"930979","DOI":"10.3389\/fimmu.2022.930979","article-title":"Mast cells and tryptase are linked to itch and disease severity in mycosis fungoides: results of a pilot study","volume":"13","author":"Terhorst-Molawi","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"2025062410265267900_bib46","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1182\/blood-2012-03-415638","article-title":"Mast cells play a protumorigenic role in primary cutaneous lymphoma","volume":"120","author":"Rabenhorst","year":"2012","journal-title":"Blood"},{"issue":"3","key":"2025062410265267900_bib47","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2340\/00015555-1220","article-title":"Distribution and maturation of skin dendritic cell subsets in two forms of cutaneous T-cell lymphoma: mycosis fungoides and S\u00e9zary syndrome","volume":"92","author":"Schwingshackl","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"2025062410265267900_bib48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11864-016-0410-8","article-title":"Genetics of cutaneous T cell lymphoma: from bench to bedside","volume":"17","author":"Damsky","year":"2016","journal-title":"Curr Treat Options Oncol"},{"issue":"12","key":"2025062410265267900_bib49","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood-2017-02-768234","article-title":"Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E)","volume":"130","author":"Park","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2025062410265267900_bib50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.12788\/j.sder.2018.007","article-title":"Molecular advances in cutaneous T-cell lymphoma","volume":"37","author":"Bastidas Torres","year":"2018","journal-title":"Semin Cutan Med Surg"},{"issue":"1","key":"2025062410265267900_bib51","first-page":"111","article-title":"Insights into the molecular and cellular underpinnings of cutaneous T cell lymphoma","volume":"93","author":"Yumeen","year":"2020","journal-title":"Yale J Biol Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/12\/2871\/2378989\/blooda_adv-2024-014495-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/12\/2871\/2378989\/blooda_adv-2024-014495-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T14:46:07Z","timestamp":1750776367000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/12\/2871\/536425\/Spatial-transcriptomics-of-progression-gene"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,6,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024014495","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6,24]]},"published":{"date-parts":[[2025,6,11]]}}}